PRNewsWire - Health

Supplemental Health Care Releases 2025 Impact Report
Lilly presents first clinical data for its investigational, next-generation FRα targeting ADC in platinum-resistant ovarian cancer at the 2025 ASCO Annual Meeting
PharmaLogic Announces Appointment of Etienne Montagut as President and Chief Executive Officer
Arthrosi Announces Multiple Presentations at the European Alliance of Associations for Rheumatology (EULAR) Congress 2025